Qianjin Research Institute

Qianjin Pharmaceutical Research Institute is the dedicated research and development division of Zhuzhou Qianjin Pharmaceutical, a leading Chinese pharmaceutical company. The institute specializes in the modernization of Traditional Chinese Medicine (TCM) and the development of chemical drugs, with a primary focus on women's health and gynecological indications. Its portfolio includes the well-known "Qianjin" series of products, which are market leaders in China for treating pelvic inflammatory diseases. The institute operates a National Enterprise Technology Center and a Postdoctoral Research Station, facilitating advanced studies in drug delivery systems and natural product extraction. In addition to gynecology, the institute is expanding its R&D efforts into pediatrics, anti-infectives, and chronic disease management.